Haleon plc
HLN
Rangering i aksjer
#13708
Haleon plc operates as a global entity focused on developing, manufacturing,... Haleon plc operates as a global entity focused on developing, manufacturing, and marketing an array of consumer health products. Its operations extend across multiple continents, specifically North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers a comprehensive selection of items, encompassing therapeutic oral care, pain relief solutions, respiratory health aids, digestive wellness products, as well as vitamins, minerals, and other dietary supplements. Prominent brands within its extensive portfolio include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The firm, incorporated in 2021, was initially named DRVW 2022 plc before rebranding to Haleon plc in February 2022. Its corporate headquarters are located in Brentford, United Kingdom.
Aksjekurs
$5.08
Sist synkronisert: 2026-10-16
Markedsverdi
$447.23M
Endring (1 dag)
-0.11%
Endring (1 år)
7.96%
Land
GB
Handel Haleon plc (HLN)
Kategori
Healthcare
Markedsverdi av Haleon plc(HLN)
Markedsverdi: $447.23M
Per October 2026 har Haleon plc en markedsverdi på $447.23M. Dette gjør Haleon plc til det 13708th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Haleon plc fra 2022 til 2026
HLN sammenlignet med topp 5 mest populære stocks
